journal article·2018-09

Reactive oxygen species scavenging with a biodegradable, thermally responsive hydrogel compatible with soft tissue injection

Yang Zhu, Yasumoto Matsumura, Murugesan Velayutham, Lesley M. Foley, T. Kevin Hitchens, William R. Wagner

Biomaterials· Volume 177
Publisher page

Abstract

Tissue damage and the impairment of regenerative processes by excessive reactive oxygen species (ROS) contributes to the pathogenesis of various diseases in soft tissues including diabetes, atherosclerosis, Parkinson's disease and myocardial ischemic/reperfusion injury. In this study, a thermally responsive injectable hydrogel poly(NIPAAm-co-VP-co-MAPLA-co-MATEMPO) (pNVMT, NIPAAm: N-isopropylacrylamide, VP: vinylpyrrolidone, MAPLA: methacrylate-polylactide, MATEMPO: methacrylate-TEMPO, TEMPO: 4-amino-TEMPO or 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl) incorporating recyclable ROS scavenging nitroxide radicals on the polymer backbone was developed to locally control adverse tissue effects from free radical generation. In an in vitro oxidative environment, TEMPO Gel significantly preserved cell viability. In a rat myocardial infarction/reperfusion model, TEMPO Gel diffused through the infarcted myocardium, integrated with the tissue upon gelation, and remained for over one week as visualized by MRI. The TEMPO Gel reduced infarction/reperfusion injury and preserved left ventricle geometry. This thermally responsive hydrogel was demonstrated to have properties desirable for local application to soft tissue beds where oxidative damage by ROS is of concern in pathological mechanisms.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Ischemia and Reperfusion · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. The role of oxidative stress in Parkinson's disease10.3233/JPD-130230 ↗
2. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis
3. Oxidative stress and left ventricular remodelling after myocardial infarction
4. Factors that impair wound healing
5. Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species
6. Reactive oxygen species in inflammation and tissue injury
7. Reactive oxygen species and fibrosis: further evidence of a significant liaison10.1007/s00441-016-2445-3 ↗
8. Oxidative stress and pulmonary fibrosis10.1016/j.bbadis.2012.11.021 ↗
9. Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms10.1097/CRD.0b013e31823dbbad ↗
10. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat10.1161/01.CIR.0000016721.84535.00 ↗
11. Oxidative stress and antioxidant therapy in Parkinson's disease10.1016/0301-0082(95)00029-1 ↗
12. The benefits of oxidative stress for tissue repair and regeneration10.1080/19336934.2016.1188232 ↗
13. Regulation of signal transduction by reactive oxygen species in the cardiovascular system10.1161/CIRCRESAHA.116.303584 ↗
14. Cardiac mitochondria and reactive oxygen species generation10.1161/CIRCRESAHA.114.300559 ↗
15. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries10.1002/adhm.201300576 ↗
16. Reactive oxygen species enhance insulin sensitivity10.1016/j.cmet.2009.08.009 ↗
17. Learning from failure: congestive heart failure in the postgenomic age10.1172/JCI200524477 ↗
18. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease
19. Chronic reactive oxygen species exposure inhibits glucose uptake and causes insulin resistance in C2C12 myotubes10.1016/j.bbrc.2016.08.028 ↗
20. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure10.1111/j.1527-5299.2002.00717.x ↗
21. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches10.2174/138920112798868782 ↗
22. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles10.1016/j.biomaterials.2011.07.014 ↗
23. Controlled release of an anti-inflammatory drug using an ultrasensitive ROS-responsive gas-generating Carrier for localized inflammation inhibition10.1021/jacs.5b08057 ↗
24. Drug-free ROS sponge polymeric microspheres reduce tissue damage from ischemic and mechanical injury10.1021/acsbiomaterials.6b00804 ↗
25. ROS-responsive drug delivery systems10.1002/btm2.10014 ↗
26. Cell protective, ABC triblock polymer-based thermoresponsive hydrogels with ROS-triggered degradation and drug release10.1021/ja507626y ↗
27. Supersensitive oxidation-responsive biodegradable PEG hydrogels for glucose-triggered insulin delivery10.1021/acsami.7b08372 ↗
28. Diselenide-containing poly(ε-caprolactone)-based thermo-responsive hydrogels with oxidation and reduction-triggered degradation10.1016/j.mtchem.2017.03.004 ↗
29. Oxidative stress and heart failure10.1152/ajpheart.00554.2011 ↗
30. Oxidative stress and cardiac repair/remodeling following infarction10.1097/MAJ.0b013e318157388f ↗
31. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis10.1161/01.CIR.99.22.2934 ↗
32. Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability10.1021/bm1004299 ↗
33. Oxidative stress in dilated cardiomyopathy caused by MYBPC3 mutation
34. A chitosan-glutathione based injectable hydrogel for suppression of oxidative stress damage in cardiomyocytes10.1016/j.biomaterials.2013.08.031 ↗
35. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction10.1016/j.biomaterials.2015.12.002 ↗
36. Mapping ischemic risk region and necrosis in the isolated heart using EPR imaging10.1002/mrm.10473 ↗
37. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal10.1038/416763a ↗
38. Recovery of oxidative stress-induced damage in Cisd2-deficient cardiomyocytes by sustained release of ferulic acid from injectable hydrogel10.1016/j.biomaterials.2016.06.060 ↗
39. Vitro study of electroactive tetraaniline-containing thermosensitive hydrogels for cardiac tissue engineering10.1021/bm4018963 ↗
40. Novel angiogenesis therapeutics by redox injectable hydrogel - regulation of local nitric oxide generation for effective cardiovascular therapy10.1016/j.biomaterials.2018.03.023 ↗
41. An injectable oxygen release system to augment cell survival and promote cardiac repair following myocardial infarction10.1038/s41598-018-19906-w ↗
42. Effects of tempol and redox-cycling nitroxides in models of oxidative stress10.1016/j.pharmthera.2010.01.003 ↗
43. Chemistry and antihypertensive effects of tempol and other nitroxides10.1124/pr.108.000240 ↗
44. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration10.1021/tx990159t ↗
45. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide10.1073/pnas.89.12.5537 ↗
46. Comparison of inhibitors of superoxide generation in vascular smooth muscle cells10.1111/j.1476-5381.2009.00259.x ↗
47. Redox-active injectable gel using thermo-responsive nanoscale polyion complex flower micelle for noninvasive treatment of local inflammation10.1016/j.jconrel.2013.10.009 ↗
48. Design of high-performance anti-adhesion agent using injectable gel with an anti-oxidative stress function10.1016/j.biomaterials.2015.08.018 ↗
49. Novel antioxidative nanotherapeutics in a rat periodontitis model: reactive oxygen species scavenging by redox injectable gel suppresses alveolar bone resorption10.1016/j.biomaterials.2015.10.077 ↗
50. Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics10.1016/j.biomaterials.2016.01.029 ↗
51. Development of a local anesthetic lidocaine-loaded redox-active injectable gel for postoperative pain management10.1016/j.actbio.2017.04.031 ↗
52. Tailoring the degradation rates of thermally responsive hydrogels designed for soft tissue injection by varying the autocatalytic potential10.1016/j.biomaterials.2015.02.100 ↗
53. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release10.1152/physrev.00026.2013 ↗
54. Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP Depletion, opening of mitochondrial permeability transition, and programmed cell death10.1104/pp.010999 ↗
55. The superoxide dismutase mimic TEMPOL protects cultured rabbit lens epithelial cells from hydrogen peroxide insult10.1006/exer.1993.1068 ↗
56. Design of a coupled thermoresponsive hydrogel and robotic system for postinfarct biomaterial injection therapy10.1016/j.athoracsur.2016.02.082 ↗
57. Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy10.1021/bm4010639 ↗
58. Water-proton relaxivity of hyperbranched polymers carrying TEMPO radicals10.1002/mrc.2384 ↗
59. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents10.1158/1078-0432.CCR-05-2747 ↗
60. Synthesis and in vitro phantom NMR and MRI studies of fully organic free radicals, TEEPO-glucose and TEMPO-glucose, potential contrast agents for MRI10.1039/C4RA11455H ↗
61. Guided and magnetic self-assembly of tunable magnetoceptive gels10.1038/ncomms5702 ↗